These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4762828)

  • 21. Carbohydrate-induced hypertriglyceridemia: inhibition by phenformin.
    Owen WC; Kreisberg RA; Siegal AM
    Diabetes; 1971 Nov; 20(11):739-44. PubMed ID: 5115588
    [No Abstract]   [Full Text] [Related]  

  • 22. [Changes of some parameters of fat and carbohydrate metabolism in weight loss in obese patients].
    Irsigler K; Waldhäusl W
    Wien Klin Wochenschr; 1969 Jul; 81(29):534-6. PubMed ID: 5801624
    [No Abstract]   [Full Text] [Related]  

  • 23. [Plasma levels of triglycerides, cholesterol, non-esterified fatty acids and uric acid, during oral glucose load, in subjects with type II diabetes and diminished glucose tolerance].
    Sinagra D; Botta RM; Lo Curzio E; Cerasola GA
    Boll Soc Ital Biol Sper; 1982 Aug; 58(15):964-70. PubMed ID: 6751356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone secretion in primary endogenous hypertriglyceridemia.
    Muggeo M; Fedele D; Tiengo A; Crepaldi G
    Horm Metab Res; 1973 May; 5(3):224-5. PubMed ID: 4714551
    [No Abstract]   [Full Text] [Related]  

  • 25. Diabetes, insulin resistance and dyslipidaemia in lipodystrophic HIV-infected patients on highly active antiretroviral therapy (HAART).
    Vigouroux C; Gharakhanian S; Salhi Y; Nguyen TH; Chevenne D; Capeau J; Rozenbaum W
    Diabetes Metab; 1999 Sep; 25(3):225-32. PubMed ID: 10499191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circadian variations of carbohydrate tolerance in maturity onset diabetics treated with sulfonylureas.
    Göschke H; Denes A; Girard J; Collard F; Berger W
    Horm Metab Res; 1974 Sep; 6(5):386-91. PubMed ID: 4417576
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of oral administration of sucrose on the turnover rate of plasma free fatty acids and on the esterification rate of plasma free fatty acids to plasma triglycerides in normal subjects, patients with primary endogenous hypertriglyceridemia, and patients with well controlled diabetes mellitus.
    Bolzano K; Sandhofer F; Sailer S; Braunsteiner H
    Horm Metab Res; 1972 Nov; 4(6):439-46. PubMed ID: 4655498
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of weight reduction on insulin responsiveness and triglyceride levels in patients with endogenous hypertriglyceridaemia.
    De Vries O; Sluiter WJ; Reitsma WD; Doorenbos H
    Neth J Med; 1974; 17(4-5):212-19. PubMed ID: 4465727
    [No Abstract]   [Full Text] [Related]  

  • 29. [Blood sugar, insulin, and blood lipid disorders after oral administration of glucose and medium-chain triglycerides in diabetics].
    Ferlito S; Lo Furno F; Munaò F; Lunetta M
    Minerva Dietol Gastroenterol; 1978; 24(1):33-42. PubMed ID: 740266
    [No Abstract]   [Full Text] [Related]  

  • 30. The University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. V. Evaluation of pheniformin therapy.
    Diabetes; 1975; 24 Suppl 1():65-184. PubMed ID: 1090475
    [No Abstract]   [Full Text] [Related]  

  • 31. Diabetes mellitus and obesity: phenformin hydrochloride as a research tool.
    Danowski TS
    Metabolism; 1967 Sep; 16(9):865-9. PubMed ID: 4860366
    [No Abstract]   [Full Text] [Related]  

  • 32. Beneficial effects of metformin in normoglycemic morbidly obese adolescents.
    Kay JP; Alemzadeh R; Langley G; D'Angelo L; Smith P; Holshouser S
    Metabolism; 2001 Dec; 50(12):1457-61. PubMed ID: 11735093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma-insulin response to glucose and circulating serum lipid levels in first-degree relatives of diabetic patients.
    Jakobson T
    Ann Clin Res; 1972 Apr; 4(2):70-7. PubMed ID: 5028067
    [No Abstract]   [Full Text] [Related]  

  • 34. Type IV hyperlipoproteinemia. A critical appraisal.
    Schonfeld G; Kudzma DJ
    Arch Intern Med; 1973 Jul; 132(1):55-62. PubMed ID: 4716427
    [No Abstract]   [Full Text] [Related]  

  • 35. Rhaponticin from rhubarb rhizomes alleviates liver steatosis and improves blood glucose and lipid profiles in KK/Ay diabetic mice.
    Chen J; Ma M; Lu Y; Wang L; Wu C; Duan H
    Planta Med; 2009 Apr; 75(5):472-7. PubMed ID: 19235684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The studies on the mechanism for hyperlipidemias--from the view point of removal of exogenous fats].
    Shigematsu H
    Nihon Naika Gakkai Zasshi; 1973 Jun; 62(6):583-92. PubMed ID: 4738334
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of primary hyperlipoproteinemias type IV with different biguanides (author's transl)].
    Weisweiler P; Schwandt P
    Klin Wochenschr; 1976 Mar; 54(6):283-5. PubMed ID: 177803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of triglyceridemia level on glucose tolerance and insulinemia in subjects with type IV hyperlipoproteinemia.
    Debry G; Drouin P; Mejean L
    Horm Metab Res; 1974 Sep; 6(5):421-2. PubMed ID: 4425070
    [No Abstract]   [Full Text] [Related]  

  • 39. Variability in blood cholesterol, triglycerides, free fatty acids, glucose and body weight in maturity-onset diabetics.
    Hulse M; Gershberg H
    Am J Med Sci; 1969 Aug; 258(2):114-20. PubMed ID: 5805233
    [No Abstract]   [Full Text] [Related]  

  • 40. Diabetes mellitus and obesity: phenformin hydrochloride as a research tool. Concluding remarks.
    Danowski TS
    Ann N Y Acad Sci; 1968 Mar; 148(3):958-62. PubMed ID: 5241487
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.